Education
About Us
Working with TipRanks
Follow Us
NOVARESE,Inc. (JP:9160)
:9160
9160 Stock Chart & Stats
¥335.00
¥3.00(0.99%)
At close: 4:00 PM EST
¥335.00
¥3.00(0.99%)
Day’s Range― - ―
52-Week Range¥272.00 - ¥369.00
Previous CloseN/A
Volume23.50K
Average Volume (3M)21.96K
Market Cap
¥8.40B
Enterprise Value¥19.69B
Total Cash (Recent Filing)¥2.40B
Total Debt (Recent Filing)¥14.34B
Price to Earnings (P/E)9.3
Beta0.32
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.49
Shares Outstanding25,073,093
10 Day Avg. Volume24,400
30 Day Avg. Volume21,960
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
9160 FAQ
What was NOVARESE,Inc.’s price range in the past 12 months?
NOVARESE,Inc. lowest stock price was ¥272.00 and its highest was ¥369.00 in the past 12 months.
What is NOVARESE,Inc.’s market cap?
NOVARESE,Inc.’s market cap is ¥8.40B.
When is NOVARESE,Inc.’s upcoming earnings report date?
NOVARESE,Inc.’s upcoming earnings report date is Nov 13, 2025 which is in 21 days.
How were NOVARESE,Inc.’s earnings last quarter?
NOVARESE,Inc. released its earnings results on Aug 14, 2025. The company reported ¥13.49 earnings per share for the quarter, beating the consensus estimate of N/A by ¥13.49.
Is NOVARESE,Inc. overvalued?
According to Wall Street analysts NOVARESE,Inc.’s price is currently Overvalued.
Does NOVARESE,Inc. pay dividends?
NOVARESE,Inc. does not currently pay dividends.
What is NOVARESE,Inc.’s EPS estimate?
NOVARESE,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NOVARESE,Inc. have?
NOVARESE,Inc. has 25,073,093 shares outstanding.
What happened to NOVARESE,Inc.’s price movement after its last earnings report?
NOVARESE,Inc. reported an EPS of ¥13.49 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.946%.
Which hedge fund is a major shareholder of NOVARESE,Inc.?
Currently, no hedge funds are holding shares in JP:9160
Company Description
NOVARESE,Inc.
NOVARESE, Inc. (9160) is a dynamic company operating in the biotechnology sector, specializing in the development and commercialization of innovative healthcare solutions. The company focuses on creating advanced therapeutics and diagnostic tools aimed at addressing unmet medical needs in various therapeutic areas, including oncology and rare diseases. NOVARESE leverages cutting-edge research and technology to enhance patient outcomes and improve overall health management.
Technical Analysis
ESCRIT Inc.
―
IKK Holdings Co., Ltd
―
Brass Corp.
―
TEAR Corp.
―
Take and Give. Needs Co., Ltd.
―